Data shows the drug works. It’s not the miracle
Post# of 148171
Over promising and under delivering has brought us to $2.
No doubt BP has seen the results and are smart enough to recognize LL has some value.
Question is how cheap to we need to be to be a buyout target? Could we possibly see a bidding war?
I have pretty much given up hope for CYDY getting this thing to market. I don’t totally blame them. It’s the system that shows extreme favoritism for large, established companies. They have the lobbyists, they make the rules.